550 related articles for article (PubMed ID: 18950657)
1. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease.
Edwards MR; Bartlett NW; Clarke D; Birrell M; Belvisi M; Johnston SL
Pharmacol Ther; 2009 Jan; 121(1):1-13. PubMed ID: 18950657
[TBL] [Abstract][Full Text] [Related]
2. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle.
Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R
Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566
[TBL] [Abstract][Full Text] [Related]
3. Cigarette smoke induced airway inflammation is independent of NF-κB signalling.
Rastrick JM; Stevenson CS; Eltom S; Grace M; Davies M; Kilty I; Evans SM; Pasparakis M; Catley MC; Lawrence T; Adcock IM; Belvisi MG; Birrell MA
PLoS One; 2013; 8(1):e54128. PubMed ID: 23349803
[TBL] [Abstract][Full Text] [Related]
4. NF-kappaB Signaling in Chronic Inflammatory Airway Disease.
Schuliga M
Biomolecules; 2015 Jun; 5(3):1266-83. PubMed ID: 26131974
[TBL] [Abstract][Full Text] [Related]
5. Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors.
Newton R; Holden NS; Catley MC; Oyelusi W; Leigh R; Proud D; Barnes PJ
J Pharmacol Exp Ther; 2007 May; 321(2):734-42. PubMed ID: 17322026
[TBL] [Abstract][Full Text] [Related]
6. Small Molecule NF-κB Pathway Inhibitors in Clinic.
Ramadass V; Vaiyapuri T; Tergaonkar V
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32708302
[TBL] [Abstract][Full Text] [Related]
7. Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD.
Caramori G; Adcock IM; Ito K
Curr Opin Investig Drugs; 2004 Nov; 5(11):1141-7. PubMed ID: 15573863
[TBL] [Abstract][Full Text] [Related]
8. NF-kappaB inhibitors for the treatment of inflammatory diseases and cancer.
Calzado MA; Bacher S; Schmitz ML
Curr Med Chem; 2007; 14(3):367-76. PubMed ID: 17305539
[TBL] [Abstract][Full Text] [Related]
9. Bu-Shen-Fang-Chuan formula attenuates cigarette smoke-induced inflammation by modulating the PI3K/Akt-Nrf2 and NF-κB signalling pathways.
Li Q; Wang G; Xiong SH; Cao Y; Liu B; Sun J; Li L; Mohammadtursun N; Yu H; Dong J; Wu J
J Ethnopharmacol; 2020 Oct; 261():113095. PubMed ID: 32531410
[TBL] [Abstract][Full Text] [Related]
10. NF-κB-IKKβ Pathway as a Target for Drug Development: Realities, Challenges and Perspectives.
Freitas RHCN; Fraga CAM
Curr Drug Targets; 2018; 19(16):1933-1942. PubMed ID: 29468963
[TBL] [Abstract][Full Text] [Related]
11. Steroid-resistant inflammation in a rat model of chronic obstructive pulmonary disease is associated with a lack of nuclear factor-kappaB pathway activation.
Birrell MA; Wong S; Hele DJ; McCluskie K; Hardaker E; Belvisi MG
Am J Respir Crit Care Med; 2005 Jul; 172(1):74-84. PubMed ID: 15805185
[TBL] [Abstract][Full Text] [Related]
12. IκB kinase-driven nuclear factor-κB activation in patients with asthma and chronic obstructive pulmonary disease.
Gagliardo R; Chanez P; Profita M; Bonanno A; Albano GD; Montalbano AM; Pompeo F; Gagliardo C; Merendino AM; Gjomarkaj M
J Allergy Clin Immunol; 2011 Sep; 128(3):635-45.e1-2. PubMed ID: 21571356
[TBL] [Abstract][Full Text] [Related]
13. Classical NF-κB activation impairs skeletal muscle oxidative phenotype by reducing IKK-α expression.
Remels AH; Gosker HR; Langen RC; Polkey M; Sliwinski P; Galdiz J; van den Borst B; Pansters NA; Schols AM
Biochim Biophys Acta; 2014 Feb; 1842(2):175-85. PubMed ID: 24215713
[TBL] [Abstract][Full Text] [Related]
14. Ergosterol attenuates cigarette smoke extract-induced COPD by modulating inflammation, oxidative stress and apoptosis
Sun X; Feng X; Zheng D; Li A; Li C; Li S; Zhao Z
Clin Sci (Lond); 2019 Jul; 133(13):1523-1536. PubMed ID: 31270147
[TBL] [Abstract][Full Text] [Related]
15. [The Rel/NF-kappa-B transcription factors: complex role in cell regulation].
Bottex-Gauthier C; Pollet S; Favier A; Vidal DR
Pathol Biol (Paris); 2002 Apr; 50(3):204-11. PubMed ID: 11980335
[TBL] [Abstract][Full Text] [Related]
16. Baicalin attenuates inflammation by inhibiting NF-kappaB activation in cigarette smoke induced inflammatory models.
Lixuan Z; Jingcheng D; Wenqin Y; Jianhua H; Baojun L; Xiaotao F
Pulm Pharmacol Ther; 2010 Oct; 23(5):411-9. PubMed ID: 20566376
[TBL] [Abstract][Full Text] [Related]
17. Progress towards the development of anti-inflammatory inhibitors of IKKbeta.
Bamborough P; Callahan JF; Christopher JA; Kerns JK; Liddle J; Miller DD; Morse MA; Rumsey WL; Williamson R
Curr Top Med Chem; 2009; 9(7):623-39. PubMed ID: 19689370
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the NEMO/IKKβ association complex formation, a novel mechanism associated with the NF-κB activation suppression by Withania somnifera's key metabolite withaferin A.
Grover A; Shandilya A; Punetha A; Bisaria VS; Sundar D
BMC Genomics; 2010 Dec; 11 Suppl 4(Suppl 4):S25. PubMed ID: 21143809
[TBL] [Abstract][Full Text] [Related]
19. Nuclear factor kappa B is a promising therapeutic target in inflammatory lung disease.
Park GY; Christman JW
Curr Drug Targets; 2006 Jun; 7(6):661-8. PubMed ID: 16787168
[TBL] [Abstract][Full Text] [Related]
20. Diverse agents act at multiple levels to inhibit the Rel/NF-kappaB signal transduction pathway.
Epinat JC; Gilmore TD
Oncogene; 1999 Nov; 18(49):6896-909. PubMed ID: 10602465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
